Douglas Grossman

Professor
Department of Dermatology
Huntsman Cancer Institute
United States of America

Professor Dermatology
Biography

Douglas Grossman, MD, PhD, is an expert in the early diagnosis and treatment of skin cancers. He received his medical degree from Baylor College of Medicine in 1994, and completed his dermatology training at Yale University School of Medicine in 1998. Following a research fellowship in cancer biology at Yale, he was recruited to the University of Utah in 2001. He sees patients with a personal history of skin cancer or excessive sun exposure, and those at increased risk for melanoma who may have numerous or atypical moles or family members with melanoma. He directs the Mole Mapping Program at the Huntsman Cancer Institute.

Research Intrest

Melanoma Moles p16 Tumor Suppressor Survivin Metastasis Oxidative Stress Chemoprevention

List of Publications
Goodson AG, Cotter MA, Cassidy P, Wade M, Florell SR, Liu T, Boucher KM, Grossman D (2009). Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention. Clin Cancer Res, 15(23), 7434-40.
McKenzie JA, Liu T, Goodson AG, Grossman D (2010). Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation. Cancer Res, 70(20), 7927-37.
Goodson AG, Florell SR, Hyde M, Bowen GM, Grossman D (2010). Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg, 36(7), 1087-98.
Jenkins NC, Liu T, Cassidy P, Leachman SA, Boucher KM, Goodson AG, Samadashwily G, Grossman D (2011). The p16(INK4A) tumor suppressor regulates cellular oxidative stress. Oncogene, 30(3), 265-74.
Goodson AG, Florell SR, Boucher KM, Grossman D (2011). A decade of melanomas: identification of factors associated with delayed detection in an academic group practice. Dermatol Surg, 37(11), 1620-30.